BIO 2020: AI patents and secrets
16-06-2020
Andrii Vodolazhskyi / Shutterstock.com
As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.
Nine days before the World Health Organization officially notified the public of a flu-like outbreak in China, BlueDot, a Canadian artificial intelligence (AI) startup, warned its clients of a potential outbreak near a market in Wuhan, China.
On December 31, 2019, BlueDot, using machine learning and natural-language processing to scour through foreign language news reports and medical bulletins in many languages, alerted public health officials in Canada and elsewhere of the outbreak and identified the countries that were most at risk, based on airline ticket data.
Breaking new ground
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
IPOS International, COVID-19, WHO, artificial intelligence, machine learning, Alibaba, pandemic, patents, innovation, healthcare, software, trade secrets
